Title of Invention

A NEUBLASTIN POLYPEPTIDE

Abstract The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
Full Text

Documents:

837-MUMNP-2003-ABSTRACT(25-8-2009).pdf

837-mumnp-2003-abstract(granted)-(28-8-2009).pdf

837-MUMNP-2003-CANCELLED PAGES(25-8-2009).pdf

837-MUMNP-2003-CANCELLED PAGES(8-8-2008).pdf

837-mumnp-2003-cancellled pages(8-2-2008).pdf

837-MUMNP-2003-CLAIMS(25-8-2009).pdf

837-MUMNP-2003-CLAIMS(8-8-2008).pdf

837-mumnp-2003-claims(amanded)-(25-8-2009).pdf

837-MUMNP-2003-CLAIMS(AMENDED)-(8-8-2008).pdf

837-mumnp-2003-claims(complete)-(8-9-2003).pdf

837-mumnp-2003-claims(granted)-(28-8-2009).pdf

837-MUMNP-2003-CORRESPONDENCE(11-5-2009).pdf

837-MUMNP-2003-CORRESPONDENCE(14-5-2009).pdf

837-MUMNP-2003-CORRESPONDENCE(21-7-2009).pdf

837-mumnp-2003-correspondence(24-8-2009).pdf

837-MUMNP-2003-CORRESPONDENCE(24-8-2009)1.pdf

837-MUMNP-2003-CORRESPONDENCE(8-12-2008).pdf

837-MUMNP-2003-CORRESPONDENCE(8-8-2008).pdf

837-MUMNP-2003-CORRESPONDENCE(IPO)-(28-8-2009).pdf

837-MUMNP-2003-DESCRIPTION(COMPLETE)-(8-8-2008).pdf

837-mumnp-2003-description(complete)-(8-9-2003).pdf

837-mumnp-2003-description(granted)-(28-8-2009).pdf

837-mumnp-2003-drawing(complete)-(8-9-2003).pdf

837-mumnp-2003-drawing(granted)-(28-8-2009).pdf

837-MUMNP-2003-FORM 1(16-12-2003).pdf

837-MUMNP-2003-FORM 1(25-8-2009).pdf

837-MUMNP-2003-FORM 1(8-2-2008).pdf

837-mumnp-2003-form 1(8-9-2003).pdf

837-mumnp-2003-form 13(11-5-2009).pdf

837-mumnp-2003-form 13(16-10-2003).pdf

837-mumnp-2003-form 13(18-1-2005).pdf

837-mumnp-2003-form 13(8-2-2008).pdf

837-mumnp-2003-form 18(3-3-2006).pdf

837-mumnp-2003-form 2(8-8-2008).pdf

837-mumnp-2003-form 2(complete)-(8-9-2003).pdf

837-mumnp-2003-form 2(granted)-(28-8-2009).pdf

837-MUMNP-2003-FORM 2(TITLE PAGE)-(25-8-2009).pdf

837-MUMNP-2003-FORM 2(TITLE PAGE)-(8-2-2008).pdf

837-mumnp-2003-form 2(title page)-(complete)-(8-9-2003).pdf

837-mumnp-2003-form 2(title page)-(granted)-(28-8-2009).pdf

837-mumnp-2003-form 3(6-9-2004).pdf

837-mumnp-2003-form 3(8-2-2008).pdf

837-mumnp-2003-form 3(8-9-2003).pdf

837-mumnp-2003-form 5(8-9-2003).pdf

837-mumnp-2003-petition under rule 138(8-2-2008).pdf

837-mumnp-2003-power of authority(4-3-2004).pdf

837-mumnp-2003-power of authority(8-2-2008).pdf

837-MUMNP-2003-REPLY TO HEARING(25-8-2009).pdf

837-mumnp-2003-sequence listing(28-8-2009).pdf

837-mumnp-2003-sequence listing(8-9-2003).pdf

837-mumnp-2003-specification(amanded)-(8-2-2008).pdf

837-mumnp-2003-wo international publication report(24-8-2009).pdf

837-MUMNP-2003-WO INTERNATIONAL PUBLICATION REPORT(8-9-2003).pdf


Patent Number 235793
Indian Patent Application Number 837/MUMNP/2003
PG Journal Number 36/2009
Publication Date 04-Sep-2009
Grant Date 28-Aug-2009
Date of Filing 08-Sep-2003
Name of Patentee BIOGEN IDEC MA INC.,
Applicant Address 14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS 02142.
Inventors:
# Inventor's Name Inventor's Address
1 DINAH WEN YEE SAH 14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS 02142.
2 TEIT E. JOHANSEN NS GENE A/S, BALTORPVEJ 154, DK-2750 BALLERUP.
3 ANTHONY ROSSOMANDO 50 ASTI AVENUE, REVERE, MASSACHUSETTS 02151.
PCT International Classification Number C12N15/12 C07K14/475
PCT International Application Number PCT/EP02/02691
PCT International Filing date 2002-03-12
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 09/804,615 2001-03-12 U.S.A.